Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciro Manzo

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Neurosci|September 22, 2025
Catatonia in Systemic Lupus ErythematosusCiro Manzo, Jordi Serra-Mestres, Marco Isetta
Rheumatology (Oxford, England)|July 24, 2021
Comment on: Comorbidities (excluding lymphoma) in Sjögren's syndromeCiro Manzo, Jordi Serra-Mestres, Marco Isetta
Reumatologia|July 21, 2020
Polymyalgia rheumatica with normal inflammatory indices at the time of diagnosis: can we just move a step forward?Ciro Manzo, Marcin Milchert, Maria Natale, et al.
Journal of Personalized Medicine|March 25, 2022
The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future ScenariosCiro Manzo, Elvis Hysa, Alberto Castagna, et al.
Rheumatology (Oxford, England)|May 8, 2024
Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirementCiro Manzo, Maria Natale, Marco Isetta, et al.
Clinical and Experimental Rheumatology|October 30, 2020
Polymyalgia rheumatica without elevated baseline acute phase reactantsCiro Manzo, Marcin Milchert, Maria Natale, et al.
Rheumatology (Oxford, England)|January 17, 2019
Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosisCiro Manzo, Marcin Milchert, Maria Natale, et al.
Clinical and Experimental Rheumatology|January 31, 2023
The management of patients with polymyalgia rheumatica: limitations to get it rightCiro Manzo, Maria Natale, Arvind Nune, et al.
Clinical and Experimental Rheumatology|November 19, 2021
Implications of fever on erythrocyte sedimentation rate but not on C-reactive protein concentrations at the time of diagnosis of polymyalgia rheumatica. Comments on Betrains et alMarcin Milchert, Alberto Castagna, Ciro Manzo, et al.
Medicines (Basel, Switzerland)|November 6, 2020
Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published LiteratureCiro Manzo, Marco Isetta, Maria Natale, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Neurosci|September 22, 2025
Catatonia in Systemic Lupus ErythematosusCiro Manzo, Jordi Serra-Mestres, Marco Isetta
Rheumatology (Oxford, England)|July 24, 2021
Comment on: Comorbidities (excluding lymphoma) in Sjögren's syndromeCiro Manzo, Jordi Serra-Mestres, Marco Isetta
Reumatologia|July 21, 2020
Polymyalgia rheumatica with normal inflammatory indices at the time of diagnosis: can we just move a step forward?Ciro Manzo, Marcin Milchert, Maria Natale, et al.
Journal of Personalized Medicine|March 25, 2022
The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future ScenariosCiro Manzo, Elvis Hysa, Alberto Castagna, et al.
Rheumatology (Oxford, England)|May 8, 2024
Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirementCiro Manzo, Maria Natale, Marco Isetta, et al.
Clinical and Experimental Rheumatology|October 30, 2020
Polymyalgia rheumatica without elevated baseline acute phase reactantsCiro Manzo, Marcin Milchert, Maria Natale, et al.
Rheumatology (Oxford, England)|January 17, 2019
Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosisCiro Manzo, Marcin Milchert, Maria Natale, et al.
Clinical and Experimental Rheumatology|January 31, 2023
The management of patients with polymyalgia rheumatica: limitations to get it rightCiro Manzo, Maria Natale, Arvind Nune, et al.
Clinical and Experimental Rheumatology|November 19, 2021
Implications of fever on erythrocyte sedimentation rate but not on C-reactive protein concentrations at the time of diagnosis of polymyalgia rheumatica. Comments on Betrains et alMarcin Milchert, Alberto Castagna, Ciro Manzo, et al.
Medicines (Basel, Switzerland)|November 6, 2020
Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published LiteratureCiro Manzo, Marco Isetta, Maria Natale, et al.
Pageof 9